Avidity Partners Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-169,000
| Closed | -$2.81M | – | 56 |
|
|
2025
Q1 | $2.81M | Buy |
+169,000
| New | +$2.81M | 0.54% | 44 |
|
|
2024
Q2 | – | Sell |
-588,500
| Closed | -$10.9M | – | 86 |
|
|
2024
Q1 | $10.9M | Buy |
+588,500
| New | +$10.9M | 0.35% | 69 |
|
|
2022
Q1 | – | Sell |
-300,000
| Closed | -$7M | – | 92 |
|
|
2021
Q4 | $7M | Sell |
300,000
-250,000
| -45% | -$5.84M | 0.15% | 67 |
|
|
2021
Q3 | $9.14M | Sell |
550,000
-390,000
| -41% | -$6.48M | 0.2% | 70 |
|
|
2021
Q2 | $22.9M | Buy |
+940,000
| New | +$22.9M | 0.62% | 49 |
|
|
2021
Q1 | – | Sell |
-527,600
| Closed | -$28.2M | – | 94 |
|
|
2020
Q4 | $28.2M | Buy |
+527,600
| New | +$28.2M | 0.92% | 38 |
|
|
2020
Q2 | – | Sell |
-357,000
| Closed | -$15.1M | – | 58 |
|
|
2020
Q1 | $15.1M | Buy |
357,000
+303,000
| +561% | +$12.8M | 2.08% | 17 |
|
|
2019
Q4 | $2.31M | Buy |
+54,000
| New | +$2.31M | 1.46% | 28 |
|